Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-acting inhaled dual bronchodilation in COPD: efficacy and cardiovascular safety
ChiCTR2100043128Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Shantou University Medical College
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of indacaterol + glycopyrronium and tiotropium in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by The First Affiliated Hospital of Shantou University Medical College. Primary endpoints: Pulmonary function, Electrocardiogram and 3 more. Started Jan 2021; status: recruiting.
02
Drugs
indacaterol + glycopyrroniumtiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR2100043128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043128.